Biomerica, Inc. reported $2.733 million in cash and equivalents at Aug. 31, more than twice its May 31 balance, alongside fiscal first-quarter sales of $1.265 million and a net loss of $1.232 million.
The fiscal quarter ended Aug. 31. Net sales totaled $1.265 million, compared with $1.38 million a year earlier. Biomerica’s loss was $0.37 per share; the year-earlier period produced net income of $2,000.
Its Aug. 31 cash and equivalents balance was $2.733 million; the comparable May 31 figure was $1.308 million.
